1. Home
  2. MMA vs XLO Comparison

MMA vs XLO Comparison

Compare MMA & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMA

Alta Global Group Limited

HOLD

Current Price

$0.45

Market Cap

10.5M

Sector

N/A

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.45

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMA
XLO
Founded
2013
2016
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
39.4M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
MMA
XLO
Price
$0.45
$8.45
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
456.8K
264.1K
Earning Date
05-20-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
N/A
$88.66
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$0.35
$0.46
52 Week High
$2.88
$9.25

Technical Indicators

Market Signals
Indicator
MMA
XLO
Relative Strength Index (RSI) 42.57 88.35
Support Level $0.35 $0.63
Resistance Level $0.71 N/A
Average True Range (ATR) 0.06 0.49
MACD 0.02 0.45
Stochastic Oscillator 59.39 90.50

Price Performance

Historical Comparison
MMA
XLO

About MMA Alta Global Group Limited

Mixed Martial Arts Group Ltd is a technology company operating in the martial arts and combat sports industry. The company operate four core business units: i) TrainAlta: A platform that transforms MMA fans into active participants through structured training programs like the Warrior Training Program, ii) BJJLink: A gym management platform designed for BJJ academies, offering tools for payment processing, marketing, student engagement, and content monetization, iii) Hype: A marketing platform helping gym owners, coaches, and athletes grow revenue from their audiences, iv) MixedMartialArts.com: The go-to resource for MMA news, fighter data, fight schedules, and the legendary Underground forum. Its majority of revenue is in the form of Program revenue, which consists of the license fees.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: